Literature DB >> 20737251

Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices.

Rashid Merchant1, Amish Udani, Vipla Puri, Valentina D'cruz, Deepak Patkar, Aarti Karkera.   

Abstract

OBJECTIVE: To evaluate osteopathy in thalassemia by bone mineral densitometry (BMD) and biochemical indices.
METHODS: Prospective review analysis with no follow up from 2006 to 2007 of 42 regularly transfused thalassemics aged 10-25 years (27 boys, 15 girls) was done. Anthropometry, pubertal stage and symptomatology were noted. Urinary C-terminal cross-linked telopeptide of type-1 collagen (Crosslaps) by ELISA; serum 25-OH vitamin D and osteocalcin by RIA; parathyroid hormone (PTH) and ferritin by chemiluminescence and IGF-1 by Enzyme immunoassay were evaluated. Dual Energy X-ray Absorptiometry (DEXA) of lumbar spine and femur was done on Lunar prodigy system. Data was entered and analyzed using the SPSS for Windows software. Mean comparisons were done by ANOVA 1 and data was compared using Chi-square test and p value < 0.05 was taken as significant.
RESULTS: Of 42 patients, 81% had osteoporosis by Z-score of DEXA. Urinary crosslaps was high in 55%; 36% had increased osteocalcin; 62% had low vitamin D levels; 38% had high parathyroid levels and IGF-1 was low in 52%. Mean serum ferritin level was 5344 ± 2855 ng/dl. There was statistical significance (p = 0.046) between chronological age and BMD. All 42 cases were divided into two groups: Group-1 (Normal DEXA), Group-2 (Abnormal DEXA) and analysis of biochemical indices between two groups showed no significant difference in any of the biochemical parameters.
CONCLUSION: This study revealed majority of thalassemics with inadequate chelation have bone resorption with advancing chronological age and BMD should be evaluated regularly for early diagnosis to prevent morbidity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20737251     DOI: 10.1007/s12098-010-0158-2

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  23 in total

1.  Serum zinc and its relation to bone mineral density in beta-thalassemic adolescents.

Authors:  Mir Reza Bekheirnia; Alireza Abdollah Shamshirsaz; Mohammad Kamgar; Navid Bouzari; Ghazaleh Erfanzadeh; Nima Pourzahedgilani; Seyed Mahmood Tabatabaie; Amirhooshang Abdollah Shamshirsaz; Masood Kimiagar; Fatemeh Ezzati; Bagher Larijani
Journal:  Biol Trace Elem Res       Date:  2004-03       Impact factor: 3.738

2.  Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data.

Authors:  A T Soliman; N El Banna; M Abdel Fattah; M M ElZalabani; B M Ansari
Journal:  Metabolism       Date:  1998-05       Impact factor: 8.694

3.  The pattern of bone disease in transfusion-dependent thalassemia major patients.

Authors:  K Katz; G Horev; J Goshen; H Tamary
Journal:  Isr J Med Sci       Date:  1994-08

4.  Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.

Authors:  R Dresner Pollack; E Rachmilewitz; A Blumenfeld; M Idelson; A W Goldfarb
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

5.  Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia.

Authors:  Pat Mahachoklertwattana; Vorachai Sirikulchayanonta; Ampaiwan Chuansumrit; Patcharee Karnsombat; Lulin Choubtum; Arporn Sriphrapradang; Somnuek Domrongkitchaiporn; Rojana Sirisriro; Rajata Rajatanavin
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

6.  Effects of thalassemia major on bone mineral density in late adolescence.

Authors:  Vincenzo Benigno; Silvano Bertelloni; Giampiero I Baroncelli; Luca Bertacca; Salvatore Di Peri; Liana Cuccia; Zelia Borsellino; Maria Cristina Maggio
Journal:  J Pediatr Endocrinol Metab       Date:  2003-03       Impact factor: 1.634

7.  Abnormalities in bone mineral density and bone histology in thalassemia.

Authors:  Somnuek Domrongkitchaiporn; Vorachai Sirikulchayanonta; Pantep Angchaisuksiri; Wasana Stitchantrakul; Chavasak Kanokkantapong; Rajata Rajatanavin
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

8.  Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status.

Authors:  L H Chow; J V Frei; A B Hodsman; L S Valberg
Journal:  Gastroenterology       Date:  1985-04       Impact factor: 22.682

Review 9.  New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.

Authors:  Ersi Voskaridou; Evangelos Terpos
Journal:  Br J Haematol       Date:  2004-10       Impact factor: 6.998

Review 10.  Thalassemia major 1995: older patients, new therapies.

Authors:  D Rund; E Rachmilewitz
Journal:  Blood Rev       Date:  1995-03       Impact factor: 8.250

View more
  10 in total

1.  Impaired bone formation and osteopenia in heterozygous β(IVSII-654) knockin thalassemic mice.

Authors:  Kanogwun Thongchote; Saovaros Svasti; Mayurachat Sa-ardrit; Nateetip Krishnamra; Suthat Fucharoen; Narattaphol Charoenphandhu
Journal:  Histochem Cell Biol       Date:  2011-06-09       Impact factor: 4.304

2.  Fractures and Low Bone Mineral Density in Patients with Beta Thalassemia Major.

Authors:  Rahul Naithani; Tulika Seth; Nikhil Tandon; Jagdish Chandra; H Pati; Renu Saxena; V P Choudhry
Journal:  Indian J Hematol Blood Transfus       Date:  2017-04-22       Impact factor: 0.900

3.  Bone-related complications of transfusion-dependent beta thalassemia among children and adolescents.

Authors:  Naghmeh Zahra Mirhosseini; Suzana Shahar; Majid Ghayour-Mobarhan; Abdullah Banihashem; Nor Azmi Kamaruddin; Mohammad Reza Hatef; Habib Alah Esmaili
Journal:  J Bone Miner Metab       Date:  2013-03-10       Impact factor: 2.626

Review 4.  Intestinal calcium transport and its regulation in thalassemia: interaction between calcium and iron metabolism.

Authors:  Kornkamon Lertsuwan; Kannikar Wongdee; Jarinthorn Teerapornpuntakit; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2018-02-26       Impact factor: 2.781

5.  Zoledronic Acid for Treatment of Low Bone Mineral Density in Patients with Beta Thalassemia Major.

Authors:  Rahul Naithani; Tulika Seth; Nikhil Tandon; Jagdish Chandra; V P Choudhry; H Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-27       Impact factor: 0.900

Review 6.  Vitamin D and bone health status in beta thalassemia patients-systematic review.

Authors:  P P Manolopoulos; G Lavranos; I Mamais; A Angouridis; K Giannakou; E O Johnson
Journal:  Osteoporos Int       Date:  2021-01-09       Impact factor: 4.507

Review 7.  Molecular Aspects of Bone Resorption in β-Thalassemia Major.

Authors:  Najmaldin Saki; Saeid Abroun; Fatemeh Salari; Fakher Rahim; Mohammad Shahjahani; Mohammadi-Asl Javad
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

8.  Correlation of Transferrin Saturation and Serum Ferritin with Bone Mass Density in Adult Transfusion Dependent Beta-Thalassemia Patients.

Authors:  Tubagus Djumhana Atmakusuma; Jeffry Beta Tenggara
Journal:  J Blood Med       Date:  2021-09-09

9.  Bone Mineral Density, Serum Calcium, and Vitamin D Levels in Adult Thalassemia Major Patients: Experience From a Single Center in Eastern India.

Authors:  Soumya Santra; Kunal Sharma; Ipsita Dash; Shaikat Mondal; Himel Mondal
Journal:  Cureus       Date:  2022-07-09

10.  Comparison of Bone Mineral Density in Thalassemia Major Patients with Healthy Controls.

Authors:  Mahesh Chand Meena; Alok Hemal; Mukul Satija; Shilpa Khanna Arora; Shahina Bano
Journal:  Adv Hematol       Date:  2015-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.